TSXV - Delayed Quote CAD

Ventripoint Diagnostics Ltd. (VPT.V)

Compare
0.0950
-0.0050
(-5.00%)
At close: 3:57:50 PM EST

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
NameTitlePayExercisedYear Born
Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D. Executive Chairman & Corporate Secretary 286k -- 1952
Mr. Hugh MacNaught Interim CEO, President & Director 12k -- --
Mr. Jimmy Jeon Chief Financial Officer -- -- --
Mr. Hirotaka Katagiri CTO & Business Development Division Director -- -- --
Matt Dobson Marketing Director -- -- --
Mr. Jim Graba Application Specialist & Chief Trainer -- -- --
Mr. Bart Hendriks Strategic Partnership Executive -- -- --

Ventripoint Diagnostics Ltd.

18 Hook Avenue
Unit 101
Toronto, ON M6P 1T4
Canada
416 848 4156 https://ventripoint.com
Sector: 
Healthcare
Industry: 
Medical Devices

Description

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.

Corporate Governance

Ventripoint Diagnostics Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 29, 2024 at 10:59 AM UTC

Ventripoint Diagnostics Ltd. Earnings Date

Recent Events

Related Tickers